Increased prostacyclin synthesizing activity in human ripening uterine cervix. 1981

M Tanaka, and I Morita, and S Hirakawa, and S Murota

Homogenate of human uterine cervix at delivery were incubated with radioactive arachidonic acid. A major metabolite (conversion rate, approx. 20%) was identified with 6-ketoprostaglandin F1 alpha, a metabolite of prostacyclin. The 6-ketoprostaglandin F1 alpha production in the ripening cervix was more than 6 times per wet weight and 37 times per DNA as much as that in the non-pregnant cervix.

UI MeSH Term Description Entries
D007743 Labor, Obstetric The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). Obstetric Labor
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002584 Cervix Uteri The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. Cervical Canal of the Uterus,Cervical Canal, Uterine,Ectocervix,Endocervical Canal,Endocervix,External Os Cervix,External Os of the Cervix,Uterine Cervical Canal,Cervix,Cervixes,Uterine Cervix,Canal, Endocervical,Canal, Uterine Cervical,Cervix, External Os,Cervix, Uterine,Endocervical Canals,Uterine Cervical Canals
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001095 Arachidonic Acids Eicosatetraenoic Acids,Acids, Arachidonic,Acids, Eicosatetraenoic

Related Publications

M Tanaka, and I Morita, and S Hirakawa, and S Murota
January 2008, Annals of medicine,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
March 1961, Obstetrics and gynecology,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
November 1983, American journal of obstetrics and gynecology,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
October 1981, Biochimica et biophysica acta,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
May 1988, Prostaglandins, leukotrienes, and essential fatty acids,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
March 1983, Clinical obstetrics and gynecology,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
February 2015, Clinical nuclear medicine,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
January 1985, Zhonghua fu chan ke za zhi,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
April 1980, Biochemical medicine,
M Tanaka, and I Morita, and S Hirakawa, and S Murota
February 2000, American journal of obstetrics and gynecology,
Copied contents to your clipboard!